caa a22 4500 606158537 CHVBK 20210128100620.0 cr unu---uuuuu 210128e20150801xx s 000 0 eng 10.1007/s10557-015-6593-6 doi (NATIONALLICENCE)springer-10.1007/s10557-015-6593-6 Metabolic Syndrome: Does it Differ Between Women and Men? [Elektronische Daten] [Yogita Rochlani, Naga Pothineni, Jawahar Mehta] Cardiovascular disease represents a massive healthcare burden worldwide. Gender differences in the pathophysiology, presentation and prognosis of cardiovascular disease have been described in the literature. Metabolic syndrome, characterized by a cluster of metabolic abnormalities is associated with increased risk for type 2 diabetes mellitus and atherosclerotic cardiovascular disease. With the global obesity epidemic, the prevalence of metabolic syndrome is rising rapidly in the developed as well as developing world. However, there is considerable variation in the prevalence based on geography, age, sex and, definition used for diagnosis. Data on gender related differences in metabolic syndrome is relatively scarce. Here, we aim to review the gender differences in epidemiology and pathophysiology of metabolic syndrome as well as its individual components. Knowledge of gender differences in metabolic syndrome can help design gender specific preventative and therapeutic strategies that will have a positive impact on overall population health. Springer Science+Business Media New York, 2015 Metabolic syndrome nationallicence Gender differences nationallicence Sex differences nationallicence Cardiovascular disease nationallicence Hypertension nationallicence Dyslipidemia nationallicence Insulin resistance nationallicence Obesity nationallicence Pathophysiology of metabolic syndrome nationallicence Role of hormones in metabolic syndrome nationallicence Rochlani Yogita Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut Pothineni Naga Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut Mehta Jawahar Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut Cardiovascular Drugs and Therapy Springer US; http://www.springer-ny.com 29/4(2015-08-01), 329-338 0920-3206 29:4<329 2015 29 10557 https://doi.org/10.1007/s10557-015-6593-6 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10557-015-6593-6 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Rochlani Yogita Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut NATIONALLICENCE 700 1- Pothineni Naga Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut NATIONALLICENCE 700 1- Mehta Jawahar Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA aut NATIONALLICENCE 773 0- Cardiovascular Drugs and Therapy Springer US; http://www.springer-ny.com 29/4(2015-08-01), 329-338 0920-3206 29:4<329 2015 29 10557